Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Minoxidil and finasteride effectively treat hair loss.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.